December 30, 2014 / 4:18 PM / 4 years ago

BUZZ-U.S. STOCKS ON THE MOVE-Jinpan International, Civeo, Neuroderm

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter,; for the Morning News Call newsletter, U.S. stock indexes fell on Tuesday, with major indexes pulling back from record levels as the recent trend of modest moves and low volume continued in the next-to-last trading day of the year. The Dow Jones industrial average was down 0.32 percent at 17,980.64, the S&P 500 was down 0.35 percent at 2,083.35 and the Nasdaq Composite was down 0.40 percent at 4,787.594.

** CIVEO CORP, $4.11, -50.30 pct

The company, which provides temporary housing for oilfield workers and miners, slashed its workforce on Monday and said revenue could fall by a third as slumping crude prices force oil producers to cut costs.

** JINPAN INTERNATIONAL LTD, $6.487, -11.74 pct

The company’s Chief Executive Zhiyuan Li and investor FNOF E&M Investment Ltd withdrew their proposal to take Jinpan private.

** IAMGOLD CORP, $2.56, +7.11 pct

** AURICO GOLD INC, $3.29, +7.17 pct

** NEWMONT MINING CORP, $19.35, +4.09 pct

** KINROSS GOLD CORP, $2.82, +4.83 pct

** ENDEAVOUR SILVER CORP, $2.24, +9.80 pct

** FIRST MAJESTIC SILVER CORP, $5.01, +6.82 pct

U.S.-listed shares of gold and silver miners rose after gold prices gained as the dollar weakened and the stock markets slid. Concerns over tension between Russia and the West also helped push the metal through key chart levels, triggering fresh buying.

** NEURODERM LTD, $10.0799, +63.11 pct

The pharma company said data from a mid-stage study suggested that a higher dose of its Parkinson’s drug could provide an alternative to treatments that require surgery.


Activist investor Keith Meister's Corvex Management LP reported a 7.1 percent stake in the real estate investment trust. (

** BG MEDICINES INC, $0.52, +62.50 pct

The U.S. Food and Drug Administration approved the automated version of the company’s BGM Galectin-3 test, which is used to measure galectin-3 protein levels in blood plasma.


Shares of the Canadian drugmaker rose a day after a female healthcare worker in Glasgow was diagnosed with Ebola. Tekmira said last week that it would supply one of its experimental Ebola treatments for clinical studies to be conducted in West Africa next year.

The World Health Organization said on Monday that the number of people infected by Ebola in Liberia, Sierra Leone and Guinea - the worst affected by the outbreak - has passed 20,000, with more than 7,842 deaths in the epidemic so far. (Compiled by Manya Venkatesh in Bengaluru; Editing by Kirti Pandey)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below